Discontinued — last reported Q3 '21
Insmed Revenue increased by 16.0% to $305.96M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 229.6%, from $92.82M to $305.96M. Over 4 years (FY 2021 to FY 2025), Revenue shows an upward trend with a 33.9% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
An increase indicates growth in market share or higher demand, while a decrease may signal market saturation or competitive pressure.
Represents the total consideration received from customers for the sale of goods or services, excluding any sales-relate...
Standard across all public companies; comparable to 'Net Sales' or 'Total Revenue' at peer distributors.
other_revenue_from_contract_with_customer_excluding_asse_0d5b70| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $45.37M | $46.76M | $56.12M | $53.11M | $65.22M | $67.73M | $59.30M | $65.21M | $77.23M | $79.07M | $83.69M | $75.50M | $90.34M | $93.43M | $104.44M | $92.82M | $107.42M | $142.34M | $263.84M | $305.96M |
| QoQ Change | — | +3.1% | +20.0% | -5.4% | +22.8% | +3.8% | -12.4% | +10.0% | +18.4% | +2.4% | +5.8% | -9.8% | +19.7% | +3.4% | +11.8% | -11.1% | +15.7% | +32.5% | +85.4% | +16.0% |
| YoY Change | — | — | — | — | +43.8% | +44.9% | +5.7% | +22.8% | +18.4% | +16.7% | +41.1% | +15.8% | +17.0% | +18.2% | +24.8% | +22.9% | +18.9% | +52.4% | +152.6% | +229.6% |